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Abstract The aim of this study was to determine if a
dissociation between reduced cerebral perfusion and gray
matter (GM) atrophy exists in frontotemporal dementia
(FTD). The study included 28 patients with FTD and 29
cognitive normal (CN) subjects. All subjects hadMRI at 1.5 T,
including T1-weighted structural and arterial spin labeling
(ASL) perfusion imaging. Non-parametric concordance/
discordance tests revealed that GM atrophy without hypo-
perfusion occurs in the premotor cortex in FTD whereas
concordant GM atrophy and hypoperfusion changes are found
in the right prefrontal cortex and bilateral medial frontal lobe.
The results suggest that damage of brain function in FTD,
assessed by ASL perfusion, can vary regionally despite
widespread atrophy. Detection of discordance between brain
perfusion and structure in FTD might aid diagnosis and
staging of the disease.
Keywords Frontotemporal dementia . MRI . Cerebral blood
flow . Gray matter atrophy . Statistical parametric mapping
Introduction
Frontotemporal dementia (FTD) is a devastating progressive
disorder characterized by impaired social and behavioral
functioning. It is the third most common neurodegenerative
disease after Alzheimer’s disease (AD) and Lewy body
disease (Neary et al. 1998). In general, FTD affects
individuals at an earlier age than AD and also can progress
more rapidly (McKhann et al. 2001). Many neuroimaging
studies have been performed to identify affected brain
regions in FTD and to help improve diagnostic accuracy.
For example, positron emission tomography (PET) and
single photon emission computed tomography (SPECT)
studies have shown reduced metabolism and perfusion
deficits in FTD, involving primarily the frontal lobe (Diehl
et al. 2004; Grimmer et al. 2004; Ishii et al. 1998; Jeong et
al. 2005; McMurtray et al. 2006; Pickut et al. 1997; Salmon
et al. 2003). In addition, structural magnetic resonance
imaging (MRI) studies, using regionally unbiased computa-
tional methods such as voxel-based morphometry (VBM),
revealed widespread cortical atrophy also involving the
frontal lobe and further including temporal lobe regions
(Gee et al. 2003; Grossman et al. 2004; Rosen et al. 2002;
Whitwell and Jack 2005; Whitwell et al. 2007, 2005). So far,
however, the imaging studies in FTD have assessed
functional and structural alterations separately, lacking the
ability to explore relationships between these changes. In
particular, functional alterations discordant to structural
changes or vice versa might provide valuable information
for accurate diagnosis and staging of the disease, in addition
to concordant functional and structural alterations.
In general, brain function can be indexed by perfusion
imaging. Arterial spin labeling (ASL) MRI measures brain
perfusion entirely non-invasively (Roberts et al. 1994). This
is accomplished by using the physical principles of MRI
to magnetically label blood water as an endogenous tracer
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for blood flow. Furthermore, ASL-MRI can readily be
performed in the same scan session as structural MRI.
Previous ASL-MRI studies in FTD demonstrated frontal
hypoperfusion, similar to findings using PET and SPECT
(Du et al. 2006). Moreover, hypoperfusion in FTD
remained significant even after accounting for brain atrophy
and partial gray and white matter volume variations,
implying that hypoperfusion can be independent of brain
volume loss. However, the relationship between hypoper-
fusion and brain atrophy in FTD has not been investigated
thoroughly.
Previously, our group developed a statistical method
(Hayasaka et al. 2006) to identify cross-modality relation-
ships (e.g. between perfusion and atrophy) without need to
explicitly model the relations. This method has been used in
MRI studies of AD, revealing patterns of concordant as
well as discordant regional alterations between cortical
hypoperfusion and atrophy. Especially, discordant alter-
ations of hypoperfusion without significant brain atrophy
were found predominantly in frontal lobe regions in AD
whereas atrophy without significant hypoperfusion in-
volved primarily parietal brain regions. The findings imply
that the pathological alterations in the AD brain that give
rise to imaging abnormalities can be heterogeneous. Based
on these observations in AD, the overall goal of this study
was to determine if similar concordant and discordant
alterations between cortical hypoperfusion and atrophy can
be detected in FTD.
Method
This cross-sectional study included 28 patients diagnosed
with FTD and 29 cognitively normal (CN) subjects. Of
those, 21 FTD and 25 CN subjects were included in a
previous publication (Du et al. 2006). The FTD patients
were referred from the Memory and Aging Clinic of the
University of California, San Francisco (UCSF) while the
control subjects were recruited from the community by
posting flyers. All patients were diagnosed according to
established consensus criteria (Neary et al. 1998) that were
based upon information obtained from an extensive clinical
history and physical examination. MRI was not exploited
for the diagnosis of FTD but was used to rule out other
major neuropathologies such as tumors, stroke, severe
white matter disease, or inflammation. Patients and controls
were included in the study if they were between 35 and
80 years old and had no history of brain trauma, brain
tumor, stroke, epilepsy, alcoholism, psychiatric illness, or a
systemic disease that affects brain function (e.g. hypothy-
roidism). None of the patients had a family history of FTD.
Furthermore, only FTD patients without motor neuron
disease-related symptoms, were included.
All subjects received a standard battery of neuropsycho-
logical tests, as described in detail before (Rosen et al.
2004). In brief, the tests included assessment of global
cognitive impairment by the Mini-Mental State Examina-
tion (MMSE) (Folstein et al. 1975), assessment of global
functional impairment by the Clinical Dementia Rating
(CDR) scale (Morris 1993) and assessment of executive
functions by a modified version of the Trail-Making Test
(TMT) (Rosen et al. 2004). All subjects or their legal
guardians gave written informed consent before participat-
ing in the study, which was approved by the Committees of
Human Research of the University of California and the VA
Medical Center in San Francisco.
MRI acquisition and processing
All subjects were scanned using a Siemens 1.5 T Vision
MRI system (Siemens Inc, Erlangen, Germany) equipped
with a quadrature channel head coil. T1-weighted structural
images were acquired using a magnetization prepared
rapid acquisition gradient-echo (MPRAGE) sequence with
repetition (TR), echo (TE) and inversion (TI) timings of 9/
4/300 ms, respectively, 15° flip angles, 1.0×1.0 mm² in
plane resolution based on a 256×256 acquisition matrix
and 154 coronal slices, each 1.5 mm thick. In addition,
perfusion weighted images (PWI) were acquired using the
concept of pulsed arterial spin labeling by double inver-
sions with proximal labeling of both tag and control images
(DIPLOMA) as described in reference (Jahng et al. 2003).
The parameters of PWI were TR/TE=2,500/15 ms with a
post-labeling delay of 1,500 ms before the PWI signal was
mapped using single shot echo planar imaging (EPI). The
inplane resolution of EPI was 2.3×2.3 mm2 based on a
128×128 acquisition matrix. For each perfusion scan, 5
slices each 8 mm thick and 2 mm gap covering the brain
regions above the AC-PC line were acquired. More details
about the PWI acquisition are described in Johnson et al.
(2005).
All images were processed as described in detail
previously (Johnson et al. 2005). In short, each PWI was
co-registered to a reference EPI (without labeling), which in
turn was co-registered to the corresponding T1-weighted
image using affine transformations with 9 degrees of
freedom and the normalized mutual information co-
registration algorithm available in the Statistical Parametric
Mapping (SPM2) program (Welcome Department of
Imaging Neuroscience; London, UK). Furthermore, the
T1-weighted images were segmented into probabilistic
maps of gray matter (GM), white matter (WM) and
cerebrospinal fluid (CSF) using Expectation-Maximization
Segmentation (EMS), also available as add-on in SPM2
(Van Leemput et al. 1999, 2001). Although we did not
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express CBF in absolute units, the differences between the
two groups are still valid, especially since we accounted for
global variations in CBF across the subjects.
Then the probabilistic tissue maps were blurred to the
resolution of PWI to estimate the GM, WM and CSF
content of each voxel in the corresponding PWI image.
Partial volume effect (PVE) correction for CSF was
calculated for each voxel on the perfusion image on the
basis of the method by Müller-Gärtner et al. (1992), which
assumes that all contributions to perfusion are from brain
tissue and that CSF contributes nothing. Furthermore, to
account for variable amounts of GM and WM in the voxels,
it was assumed that perfusion of GM is 2.5 times the
perfusion of WM (Roberts et al. 1994), leading to corrected
PWI intensities according to: SIcorr=SIuncorr / (GM+
0.4*WM), where SIcorr and SIuncorr are the corrected and
uncorrected perfusion signal intensities, respectively, and
GM and WM are the corresponding probabilities of gray or
white matter volumes, respectively, with GM+WM+CSF=1.
To constrain the analysis to GM perfusion (since the PWI
signal of WM is usually very small and CSF contributes only
noise), a threshold was applied that included only voxels with
at least 75% gray matter and less than 25% other brain tissue,
such as white matter and cerebrospinal fluid. Finally, to reduce
high signal artifacts in PWI (i.e. signal from blood vessels),
PWI signals above two standard deviations of the mean signal
were capped to a maximum of two standard deviations above
the SIcorr. For voxelwise tests the T1-weighted images were
spatially normalized to a study-specific brain template. The
study-specific template was created by averaging the
spatially normalized T1-weighted images of all subjects in
the study using an initial affine transformation with 12
degrees of freedom, followed by non-linear transformations
with 10×9×10 discrete cosine basis functions. To test for
regional brain atrophy, the T1-weighted images also were
segmented, smoothed (6 mm isotropic Gaussian), and
modulated according to the optimized VBM protocol as
outlined by Good et al. (2001).
To test for regional hypoperfusion, the PWI images were
normalized to the T1-weighted template space by applying the
same transformation parameters than for the T1-weighted
images. In addition, the PWI images were re-sliced to 2×2×
2 mm voxel size and smoothed with a 12-mmGaussian kernel
to account for imperfection in co-registration.
Statistical analysis
Initially, voxelwise tests of differences in GM atrophy or
GM perfusion between FTD and CN subjects were
performed separately using two sample t-tests. For GM
atrophy the t-tests were further augmented by an analysis of
co-variance (ANCOVA) with adjustments for variations in
age and total intra-cranial volumes. Similarly, for hypo-
perfusion the t-tests were augmented by ANCOVA with
adjustments for variations in age and global perfusion to
account for global variations in blood flow between
subjects. The level of significance for these tests was set
at p=0.05, including adjustments for multiple comparisons
based on the concept of false discovery rates (FDR)
(Genovese et al. 2002).
Following the t-tests, a concordant/discordant analysis
was performed. For the concordant/discordant analysis of
GM atrophy and hypoperfusion changes, we used a non-
parametric multimodal correlation test as described in our
previous report (Hayasaka et al. 2006). In brief, this test
performs a statistic on the T-values of both GM atrophy,
denoted here SGM and T-values of hypoperfusion, denoted
SPerf. The analysis includes first, the design of combining
functions of concordance or discordance between GM
atrophy and hypoperfusion, followed by permutation tests
to obtain the distribution of each combining function and to
perform a statistic.
We defined the following combining functions:
(1) Concordance function: WCON=SGM×Sperf, identifies
regions of concordance between GM atrophy and
hypoperfusion. For statistical inference of the concor-
dance function, we set the critical threshold of T-
values for concordance to a value equivalent to the
joint distribution of atrophy and perfusion at p<0.05
statistical significance with a family-wise error (FWE)
adjustment for multiple comparisons, as illustrated in
Fig. 1.
(2) Discordance functions: WDIS=Sperf − (λ×SGM)2η iden-
tifies regions with changes in GM perfusion without
substantial GM atrophy. Here, λ defines the width and
η the base of the parabolic function. Conversely,
WDIS=SGM− (λ×Sperf)2η identifies regions with
changes in GM atrophy without substantial hypoperfu-
sion. We chose parabolic functions to impose smooth
boundaries for critical regions of discordance. Further-
more, we chose λ=0.5 so that critical regions of
discordance roughly span a range from −2≤T≥2 and
a typical t-test fails to reject the null hypothesis at p=
0.05 in such regions. Also we chose η=2 to be wider
than a typical parabola (i.e. η=1) to increase the
sensitivity in the critical regions. More details about
these functions and settings are described in Hayasaka
et al. (2006) and Zhang et al. (2008).
Figure 1 shows a scatter plot of T-values of GM
perfusion versus GM atrophy from a t-test comparing
FTD to CN subjects. Also illustrated are the various
combining functions at a statistical threshold of p=0.05
(FWE).
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To determine the statistical distribution of voxels defined
by each combining function, we performed permutation
tests on the group of subjects and used the cluster mass of
voxels as a test statistic. These tests were conducted using
the Statistical non-Parametric Mapping (SnPM) package
(http://www.sph.umich.edu/ni-stat/SnPM).
The level of statistical significance in imaging tests was
set to p<0.05. We used the concept of false discovery rate
(FDR) (Genovese et al. 2002) to account for multiple
comparisons in separate imaging tests of brain atrophy and
hypoperfusion. To account for multiple comparisons in
concordance/discordance tests of brain atrophy and hypo-
perfusion, we used adjustments based on FWE, which are
more stringent than those based on FDR.
P-values less than the threshold were then linked to their
corresponding anatomical localizations and superimposed
on a brain map.
Result
Table 1 lists the demographics and clinical data of the study
population. This shows a trend for FTD patients being
moderately younger than control subjects (p=0.06). The
groups did not differ significantly by gender (χ2=0.3, p=
0.5). As expected, FTD patients scored significantly worse
on MMSE (p<0.001), CDR (p<0.001) and modified trials
tests (p<0.001) than CN subjects.
Figure 2 shows the results from separate SPM group
analyses of GM hypoperfusion (A) and GM atrophy (B) in
FTD relative to CN subjects. Only regions that both T1-
weighted and ASL perfusion MRI covered are shown. This
indicates FTD patients had significant hypoperfusion
bilaterally in the medial frontal cortex and right prefrontal
cortex (p<0.05, FDR corrected). At the same statistical
threshold level than perfusion, GM atrophy was by far more
widespread in FTD, involving bilaterally large aspects of
the medial frontal lobe and extending into the temporal
lobes (p<0.05, FDR).
Figure 3 shows results from a concordance analysis of
reduced GM perfusion and GM atrophy in FTD relative to
controls. Concordance was found in the right prefrontal
cortex and bilateral medial frontal lobe (p<0.05, FWE
corrected).
Figure 4 shows results from a discordance analysis of
GM atrophy without significant hypoperfusion between
FTD patients and control subjects, involving bilaterally the
premotor cortex (p<0.05). A discordance analysis of
hypoperfusion without significant GM atrophy yielded no
significant region.
Discussion
The main finding of this study is that FTD was associated
with discordant cortical atrophy in absence of significant
reduction of perfusion in premotor areas whereas concor-
dant alterations of cortical atrophy and hypoperfusion
occurred predominantly in the right prefrontal cortex and
bilaterally in the medial frontal lobe. The new finding in
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Fig. 1 Scatter plot of t-values
of gray matter hypoperfusion
versus gray matter atrophy from
a t-test comparing FTD patients
with control subjects. The
cluster defining thresholds of the
combining functions at p=0.05
(adjusted for family-wise errors)
are indicated and described in
the figure legend
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Table 1 Demographic and clinical data of the patients with FTD and control (CN) subjects
Demographics FTD(n=28) CN(n=29) P values
Mean age (years) 58.9±8.4 63.8±11.1 0.06
Men/Women 17/11 15/14 0.5
MMSE (scale 0–30)a 23.0±7.2 29.7±0.8 <0.001
CDR box scores (scale 0–18)b 7.5±3.8 0±0 <0.001
Modified trials (scale 0—infinity)c 14.2±14.0 34.2±19.5 <0.001
Values are mean ± standard deviation
aMMSE: Mini Mental State Examination, decreasing scores indicating increasing cognitive impairment
b CDR: Clinical Dementia Rating score with increasing scores of sum of boxes indicating increasing cognitive impairment
cModified trails score indicating number of lines drawn per minute and hence a lower score indicating increased impairment
Fig. 2 Results, showing significant T-values from separate analyses
of GM atrophy (a) and hypoperfusion (b) in patients with fronto-
temporal dementia (FTD) compared to control subjects (p<0.05, FDR
corrected). The color scale of T-values is indicated in the lower right
corner. Only regions that were covered by both T1-weighted and ASL
perfusion MRI are shown
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this study is the detection of concordance/discordance
regions between hypoperfusion and GM atrophy in patients
with FTD, compared to a previous report involving largely
the same patients that showed only hypoperfusion. In
addition, tests of cortical atrophy and hypoperfusion in
FTD when conducted separately indicated widespread
atrophy involving large aspects of the lateral and medial
frontal lobe bilaterally and hypoperfusion in the medial
frontal and right prefrontal cortex, consistent with previous
imaging reports (Broe et al. 2003; Diehl et al. 2004; Du et
al. 2007; Gee et al. 2003; Grimmer et al. 2004; Grossman
et al. 2004; Ishii et al. 1998; Jeong et al. 2005; McMurtray
Fig. 4 Results from a discordance analysis of gray matter atrophy without significant hypoperfusion in FTD relative to control subjects. Clusters
of significant dissociation are shown (p<0.05 FWE corrected)
Fig. 3 Results from a concordance analysis of both gray matter atrophy and hypoperfusion in FTD relative to control subjects. Clusters of
significant concordance are indicated (p<0.05, FWE corrected)
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et al. 2006; Pickut et al. 1997; Rosen et al. 2002; Salmon
et al. 2003; Whitwell and Jack 2005; Whitwell et al.
2005, 2007).
We interpret the finding of discordant brain atrophy in
absence of hypoperfusion in the premotor cortex as
indication of brain tissue that is still functioning and
connected in FTD, though other explanations are possible:
First, loss of brain tissue other than neurons might
contribute disproportionately to atrophy while surviving
neurons still function normally as reflected by normal levels
of perfusion. Indeed, some histopathological studies sug-
gest that earliest cellular changes in FTD occur in
astrocytes without frank neuron loss whereas neuronal
damage is found in later stages of the disease (Broe et al.
2004; Kersaitis et al. 2004). This view is also supported by
clinical observations that many patients with FTD do not
have motor symptoms, despite apparent atrophy of the
premotor cortex. Discordant MRI perfusion in presence of
brain atrophy might provide an index for the condition of
motor neurons in FTD which atrophy alone cannot provide.
The recruited patients with FTD were all mild to moderate
stage and accounting for disease severity, e.g. using
MMSE, did not significantly alter the results. However,
given the small number of subjects and limited power, we
cannot exclude that the results might change for patients at
a more advanced stage of FTLD. Further studies permitting
concurrent assessment of structural and function alterations
in FTD are necessary to test this conjecture.
Second, it is also possible that we lacked power with
ASL-MRI to measure small alterations in hypoperfusion in
presence of GM atrophy. A conservative power analysis of
our data based on previous reliability tests (Jahng et al.
2005) suggests that the minimum difference in perfusion
we can expect to detect with 28 patients and controls and
80% power (alpha=0.05) is about 20%. In comparison, the
minimum difference in atrophy that we can detect at the
same level of power and significance is 1.5%. This may
also explain why we did not observe significant discor-
dance between hypoperfusion without GM atrophy in FTD.
In another study involving AD, however, we found regions
with significant hypoperfusion in absence of atrophy,
indicating that it is principally possible to measure
discordant alterations between atrophy and perfusion with
our method. Another issue that suggests technology rather
than biological effects explains discrepancies between
structural and perfusion findings are the typical observation
of higher SNR of the perfusion signal from the frontal
cortex, where regions are more adjacent to one another,
compared to SNR of the perfusion signal from parietal
brain regions. Hence, differences will be more datable in
frontal than parietal brain regions. We also found concor-
dant reductions of GM volume and perfusion in the right
prefrontal cortex and bilateral medial frontal lobe, regions
that have been consistently implicated in the pathology of
FTD. Since the perfusion data were corrected for CSF and
GM/WM tissue variations, the concurrent reductions in
perfusion and GM volume cannot be explained simply as an
artifact of partial volume effects. One possible explanation
for concordant atrophy and hypoperfusion is that the
remaining brain tissue is already damaged as indicated by
reduced perfusion. It is interesting that the regions showing
concurrent atrophy and hypoperfusion involved the right
prefrontal cortex and bilaterally the medial frontal lobe.
These regions are considered particularly vulnerable to
FTD, as indicated in previous imaging studies (Broe et al.
2003). In addition, we found that concordance regions in
the predominant right frontal lobe. It is consistent with
several studies (Ishii et al. 1998; McMurtray et al. 2006;
Du et al. 2006) that showed hypoperfusion and hypome-
tabolism in the predominant right frontal lobe. The clinical
significance of the metabolic and perfusion asymmetry is
unknown. One possible explanation may be caused by
sampling bias. Left-dominant patients can show language
disturbances even in early stages. Thus, it is more likely
that these patients are brought to neurology clinics. On the
other hand, right-dominant patients may present predom-
inantly with behavioral or psychiatric abnormalities, and
so are first seen as psychiatric abnormalities, and poten-
tially are misdiagnosed as having psychiatric illnesses. It
should be noted that the equivalence between structural
MRI and functional imaging, i.e. FDG-PET, in FTD has
been seen in multiple studies of the two techniques
independently but also in studies comparing the two
modalities (Kanda et al. 2008; Kipps et al. 2009).
Therefore, our findings of concordance, which agree with
these previous studies, are not surprising. Nonetheless, the
results support the equivalence between ASL measured
hypoperfusion and PET measured hypometabolism in
FTD.
The image analysis approach used in this report was
previously employed to explore the concordance/discordance
between structural and perfusion changes in patients with
AD and mild cognitive impairment (Hayasaka et al. 2006).
Our results demonstrate that the same concept applied to
FTD provides new information, not available from testing
each modality separately. The method could potentially be
used to explore the relationship between various other
imaging modalities, including PET and SPECT, in FTD
and other neurodegenerative diseases.
Several limitations in our study ought to be mentioned.
First, the patients were diagnosed clinically, without
autopsy confirmation of FTD. Thus, it is possible that
some of patients with FTD had other causes of dementia.
Studies involving brain autopsies are needed to confirm that
our findings are related to FTD pathology. The small
number of patients limits power to detect significant
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differences in perfusion and generalization of the findings.
Further studies including a larger number of patients are
warranted to confirm the findings. A technical limitation is
that this implementation of ASL-MRI in conjunction with
the short lifetime of spin labels at 1.5 T did not permit
covering more brain regions, especially the temporal lobes,
which are also susceptible to FTD. Therefore, we may have
missed other prominent regions with atrophy and hypo-
perfusion in FTD. Lack of perfusion data from the ventral
prefrontal cortex and most of the temporal lobes limit,
which both can be highly impacted in FTLD, limit the
conclusions in this study. New volumetric ASL-MRI
methods (Fernández-Seara et al. 2005; Günther et al.
2005) can provide more brain coverage, including the
temporal lobe, especially when performed at a higher
magnetic field strength than 1.5 T. Finally, another
technical limitation is that the choice of combining
functions is somewhat arbitrary and subjective and different
choices for combining functions might alter the outcome.
However, the sensitivity and robustness of the combining
functions can be evaluated by simulations and permutation
tests as we previously showed (Hayasaka and Nichols
2004). In addition, the functions we chose here are identical
to those we used in previous studies of Alzheimer’s disease
(Hayasaka et al. 2006) and brain aging (Zhang et al. 2008).
Another limitation is that our concordance/discordance
analysis is constraint to an analysis at the group level while
examinations at the single subject level might be even more
informative. In theory, a potential solution to this is
performing the concordance/discordance analysis using
each subject’s regional z-scores (deviation from the normal
mean) rather than t-scores from the group comparison,
supplemented by an appropriate statistic that takes both
between group and across subject variations into account.
In summary, we found concordant hypoperfusion and brain
atrophy in the right prefrontal cortex and bilateral medial
frontal lobe in FTD as well as discordant atrophy without
significant hypoperfusion in premotor regions. These results
suggest that damage of brain function in FTD may vary
regionally despite widespread atrophy. Detection of discor-
dance between brain perfusion and structure in FTDmight aid
diagnosis and staging of the disease.
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